Welcome to the Program for Attention, Learning, and Memory (PALM)

The Program for Attention, Learning, and Memory (PALM) is dedicated to positively impacting the lives of children and families struggling with ADHD. This is accomplished by two overarching research arms.

  • The first arm of our program is focused on advancing our understanding of neurocognitive deficits (e.g., attention, memory) in children with ADHD. Specifically, we examine how deficits in areas of neurocognition interact to adversely impact core areas of functioning (e.g., attention problems, learning). Developments in this area will lead to an improved understanding of potential causes of many of the difficulties experienced by children with ADHD as well as novel treatment targets.
  • The second arm of our program is focused on examining how a better understanding of neurocognition in individuals with ADHD might be used to improve already existing treatments as well as develop novel treatments targeted at improving underlying neurocognitive dysfunction. Our ultimate hope is that developments in these areas will lead to sustained improvements in functioning for individuals and families dealing with ADHD, particularly as they relate to learning outcomes.

PALM Undergraduate RA Lands E-Board Position!

One of the senior RAs in the PALM, Diana Ugalde, has landed a position on the executive board, as the Education Chair, of the Cognitive Neuroscience Society (CNS) in the Honors College at FIU.  PALM is very proud to announce this accomplishment!   Congratulations... read more

Director of the PALM Featured on the Brain & Behavior Research Foundation Website

Dr. Joseph Raiker, the Director of the Program for Attention, Learning, and Memory (PALM), recently had a paper he co-authored featured on the Brain & Behavior Research Foundation website. This paper highlights the use of an empirically-based approach to diagnosing ADHD and provides diagnostic likelihood ratios to clinicians using the ASEBA scales in the assessment of the disorder in hopes of improving diagnosis of the disorder. The project was funded by the National Institutes of Health (R01 MH066647) under the direction of Principal Investigator, Dr. Eric Youngstrom. The team also included Drs. Thomas W. Frazier, Robert L. Findling, Andrew Freeman, Guillermo Perez-Algorta, Joseph Calabrese, and Norah Feeny. To read more, click... read more